Samjin Pharmaceutical Co., Ltd. (005500) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Samjin Pharmaceutical Co., Ltd. (005500:KRX), powered by AI.

Current Price
₩18,350
P/E Ratio
10.1
Market Cap
244.4B
Sector
Healthcare
What is the Samjin Pharmaceutical Co., Ltd. stock price forecast?

Samjin Pharmaceutical Co., Ltd. is currently trading at ₩18,350. View real-time AI analysis on Alpha Lenz.

What is Samjin Pharmaceutical Co., Ltd. insider trading activity?

View the latest insider trading data for Samjin Pharmaceutical Co., Ltd. on Alpha Lenz.

What is Samjin Pharmaceutical Co., Ltd.'s P/E ratio?

Samjin Pharmaceutical Co., Ltd.'s P/E ratio is 10.1.

Samjin Pharmaceutical Co., Ltd.

KRX · 005500
₩18,350-290(-1.56%)
Ask about Samjin Pharmaceutical Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Samjin Pharmaceutical Co., Ltd. trades at a P/E of 10.1 (undervalued) with solid ROE of 8.8%.

Ask for details

Company Overview

Samjin Pharmaceutical Co., Ltd. is a prominent player in the pharmaceutical industry, primarily engaged in the research, development, manufacturing, and distribution of pharmaceutical products. The company focuses on the production of a diverse range of medications including prescription drugs, over-the-counter (OTC) products, and health supplements. Its portfolio addresses various therapeutic areas such as cardiovascular diseases, metabolic disorders, and microbial infections. With a strong commitment to innovation, Samjin Pharmaceutical actively invests in R&D to develop new drugs and improve existing formulations, enhancing its competitiveness in the global pharmaceutical market. Samjin also plays a crucial role in ensuring drug affordability and accessibility, particularly within the South Korean healthcare system, while maintaining high standards of quality and efficacy. As a key contributor to public health, the company continues to expand its international presence through strategic partnerships and compliance with global regulatory standards.

CEO최지현, 조규석
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees586

Company Statistics

FY 2025

Profile

₩244,422,000,000Market Cap
₩309,133,530,710Revenue
13.32MShares Out
586Employees

Margins

40.46%Gross
15.22%EBITDA
8.66%Operating
7.15%Pre-Tax
7.82%Net

Valuation

10.11P/E
0.84P/B
0.79EV/Sales
7.82EV/EBITDA
25.41P/FCF

Growth (CAGR)

4.10%Rev 3Yr
5.62%Rev 5Yr
4.93%Op Inc 3Yr
-3.64%Op Inc 5Yr
3.34%Net Inc 3Yr
-2.82%Net Inc 5Yr

Returns

5.40%ROA
8.76%ROE
6.04%ROIC

Financial Health

₩12,080,854,660Cash & Cash Equivalents
₩168,056,154,350Net Debt
62.03%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Samjin Pharmaceutical Co., Ltd. (ticker: 005500) is a company listed on KRX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 586 employees. Market cap is $244.4B.

The current price is ₩18,350 with a P/E ratio of 10.11x and P/B of 0.84x.

ROE is 8.76% and operating margin is 8.66%. Annual revenue is $309.1B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Samjin Pharmaceutical Co., Ltd. (Healthcare) Stock Forecast & Analysis ₩18,350 | Alpha Lenz